Sales commission capitalization under ASC 606 comes down to a split. The part of a payout tied to winning a contract becomes an asset the company carries and writes down over time. The part tied to ordinary selling is an expense of the period in which it is earned. The common mistake is treating the whole payout one way, which either flatters profit in a strong quarter or hides a real cost in a weak one.
The dividing line runs through the payment terms, not the name of the plan. Part of what you pay a salesperson buys something the company keeps: a signed contract with a customer who has committed to pay. The rest pays for the work of selling itself, and that cost is consumed as it happens, leaving nothing behind on the books.

In practice, a base salary draws the clearest line. It is paid for working the pipeline and being available to customers, so it stays an expense in the period it is earned. A bonus that appears only when an order is signed has an asset character, because the company now holds something it did not hold before.
Most real plans sit between those two extremes. A rep may earn a percentage of first-year value, a smaller percentage on renewals, and an accelerator for going past quota. Each piece has to be judged on its own trigger instead of being averaged into one company-wide answer that satisfies nobody.
The trade-off shows up in the monthly report. Capitalize the contract-linked piece and profit in the signing quarter looks better, while the cost returns over later periods. Expense everything at once and the signing quarter absorbs a charge that the customer relationship will pay back over time.
Many growing companies settle this at year end, with a journal entry and a rough assumption. It is easier to settle it when the plan is written, by labeling each payout component with its trigger. That label is what makes the split defensible later, when a lender or an investor asks why a commission asset sits on the balance sheet.
ASC 606 lets you record a cost as an asset only when two tests hold at the same time. The cost has to be incremental, outsourced cfo meaning you would not have paid it if the contract had never been obtained. It also has to be recoverable, meaning the contract is expected to bring in enough margin to cover it.
Incremental sounds simple until you look at a plan that pays for activity. A commission paid per demo, per proposal, or per qualified lead fails the test, because those costs would be paid whether or not the customer ever signs. The trigger tells you the answer before you look at any calculation.
Recoverability is the test that surprises founders. If you win a contract at a price that barely covers delivery, the commission tied to it may not be recoverable, and the asset does not get recorded even though the payout was clearly incremental. A profitable contract in the same quarter does not rescue the unprofitable one.
Judgment enters at the margin. A new market with thin margins and a long sales cycle makes recovery harder to support. A mature product with steady renewals makes it easier. The same commission plan can produce different answers in two parts of the same business, and that is not a contradiction.
Write the reasoning down at the time, not after a question comes up. A short memo that names the trigger, the expected benefit, and the assumption behind it does more for you than an elegant calculation nobody can reconstruct a year later. The memo is the part that survives staff changes.
A useful habit is to keep the memo to a few lines and file it next to the contract, so the two travel together. When a new accountant, a lender, or a buyer opens the file, the reasoning is already attached to the deal that produced the cost. That is a smaller effort than rebuilding the argument from an old plan document and a set of payouts that no longer match.
Once the cost is an asset, it has to be spread over the period it benefits. The starting point is expected customer life, not the stated contract term. A contract that renews predictably points to a longer period than the date printed on the order form.
That distinction matters because renewal commissions are usually expensed as incurred, while the initial commission is spread across the whole relationship. Assume a customer stays far longer than the first term and the asset unwinds slowly, which makes early profit look stronger than the cash suggests.
Expected customer life is a judgment you can support with evidence you already have. Renewal history by segment, churn patterns, product cycles, and the reason customers leave all point in a direction. Where that evidence is thin, a shorter and more conservative period is easier to defend than an optimistic one.
Apply the reasoning component by component and the shape of the answer becomes obvious.
| Payout component | Treatment | What sets the period |
|---|---|---|
| Commission on the first signed contract | Asset | Expected customer life |
| Commission on each renewal | Expense as incurred, or the expedient | Renewal period |
| Salary, draw, activity bonus | Expense | None |
| Commission on a contract with no expected margin | Expense | None |
Work through the table against your own plan and you will usually find one or two components that need a real decision. The others tend to settle quickly once the trigger is written down next to the name of the plan.
Amortization follows the transfer of the goods or services the customer buys. When a customer buys roughly the same thing every month, the asset unwinds in even slices. When the first year includes onboarding, hardware, or a heavy implementation phase, the pattern is front-loaded and the cost should follow it.
Getting the pattern wrong does not change total profit over the life of the relationship. It changes when the profit appears, which is exactly what a lender or an investor reads in a monthly report. A pattern that pushes cost into the future makes a slow quarter look better than it was.
In practice, the pattern is easier to support when it mirrors the revenue recognition already in your books. If revenue for a contract is recognized over time on a straight-line basis, a straight-line treatment of the related commission is a short argument rather than a debate.
The trade-off is effort against questions. Matching the revenue pattern takes more setup at the beginning, but a mismatched pattern invites the same question every review meeting. Once the mismatch sits in the ledger, someone has to explain it again each time the numbers are discussed.
Test the pattern at the contract level for anything unusual, and let routine contracts share a pattern that reflects the typical customer. There is no prize for the most granular calculation if nobody on the team can explain the monthly number without opening a spreadsheet.
One sign that the pattern is wrong is a sudden jump in amortization that does not match any change in sales. If the released cost climbs while the pipeline is flat, the schedule is probably spreading a benefit that the customer is no longer receiving. Finding that before close is easier than explaining it a quarter later.
The practical expedient lets you skip capitalizing a commission when the period it benefits is a year or less. It saves effort on short contracts and on plans where the accumulated cost is too small to justify the tracking, which covers a surprising share of small sales teams.
The trap is applying it by habit. If the same customer is expected to stay for several years and the initial commission is meant to buy that relationship, the expedient does not fit even when the paperwork renews on an annual cycle. The benefit period is the test, not the paper.
For renewal commissions, the common practice is to expense them as incurred, because the renewal is a fresh decision by the customer and the new commission is not incremental to the original contract. This is where the split becomes visible: the first sale is capitalized and everything after it is expensed.
Consistency across the book matters more than the choice itself. If some contracts are capitalized and similar ones are not, outsourced cfo the reports stop being comparable from month to month, and the difference is the first thing an accountant will ask about during a review.
A quick test before you decide: does this commission buy something that survives the current period? If it does, and the benefit runs past a year, capitalize it. If it does not, or the benefit is short, expense it. Then record which of the two you applied and why.
Keep the reasoning for the expedient in the same place as the rest of the method. When the answer is ”the benefit is short,” the next reader should be able to see the contract term and the expectation behind it, without hunting through email for a decision someone made two quarters ago.
Several practical choices change the reported outcome without changing the underlying economics of the deal. Knowing which ones you made, and being able to say why, is what keeps the numbers usable when a new accountant, a lender, or a buyer reviews them.
You do not have to test every contract on its own. Grouping similar contracts into a portfolio and applying one answer is permitted when the result would not differ materially from testing each contract separately. For a business with hundreds of similar subscriptions, this is the difference between a workable routine and an endless exercise.
A clawback provision complicates the picture. If a rep must return part of a commission when the customer leaves early, the cost you expect to keep is smaller than the payout, and the asset should reflect what you actually expect to bear rather than the gross amount.
Changes to the commission plan mid-relationship matter too. A new plan that pays more on renewals than the old one changes the economics of the remaining relationship, and the existing asset may need to be revisited instead of being amortized to zero on the old schedule. None of these calls is a one-time decision, so give each one a line in your close checklist.
Capitalizing changes three places at once. The balance sheet carries an asset, the income statement carries amortization instead of a single commission charge, and the cash flow statement shows the payout as an operating outflow in the month it was actually paid.
For a founder watching cash, that last point is the one that matters. The accounting split does not move money. A commission paid in March still leaves the bank account in March, whether or not the expense is spread across the rest of the year in the books.
Cash models and accrual reports therefore tell different stories in a growth year. Hiring salespeople and paying large first-year commissions creates a cash dip that the income statement smooths out, and the difference is easy to misread as an accounting problem rather than a timing one.
Investors and lenders read the balance sheet, so a commission asset shows up in working capital conversations. Being able to say what it is, how long it will unwind, and what happens if churn rises is more useful than the size of the number itself.
For internal reporting, keep a simple view: commissions paid in the period, the portion capitalized, and the amortization released. Three lines that reconcile to the ledger answer most questions before anyone has to ask them, and they take minutes to prepare once the triggers are labeled.
A treatment that depends on memory does not last. The split holds up when it is applied as a rule to a labeled file every month, not rebuilt from a discussion each time the close comes around. The label is the piece that keeps the answer stable through staff changes and busy quarters.
In practice, the labeling happens before the entry, while the commission file is still open. Each payout line gets a marker for its trigger and a note on whether it is incremental. By the time the bookkeeper posts the numbers, the treatment is already decided and no one has to reopen the plan document to guess at it.
Most growing companies run this through outsourced bookkeeping or a small in-house team, so the handoff matters. What the person closing the books needs is short and specific:
Those four items reconcile to the ledger without a long explanation. If a question comes back, it lands on a specific line rather than on the whole method, which is the difference between a five-minute answer and a meeting.
The trade-off is a little more setup at the start of each close. In exchange, the commission asset stops being a number only one person can explain, and the reports stay comparable from month to month. For a business that expects lenders or investors to look at the balance sheet, that stability is worth the extra step.
Over time the routine earns its keep in a second way. When the same labels produce the same treatment quarter after quarter, a change in the asset balance points to a real change in the business rather than to a change in how someone did the math that month.
Tiered plans, accelerators, and quotas produce commissions that do not map neatly onto individual contracts. A rep who crosses a threshold may earn a higher rate on every deal in the quarter, and the extra amount is not obviously tied to any single customer.
A workable approach is to allocate the payout across the contracts that earned it in proportion to their value, then test each allocation against the two conditions. In practice, the allocation rarely changes the answer for large deals and often turns small ones into expenses, which is the outcome you would expect anyway.
Multi-element contracts create a second problem. When a customer buys services and a subscription together, one commission covers both, and the benefit period may differ for each part. Splitting the cost along the same lines as the revenue removes the guesswork and keeps the two sets of records aligned.
Team-based and overlay commissions add a third wrinkle. A payout to a solutions engineer or a channel partner for the same deal is still incremental if it would not exist without the contract, even though that person did not close the sale personally. The trigger decides, not the job title.
The honest answer for many of these cases is that the correct treatment costs more to maintain than the difference it makes. That is a legitimate reason to choose the simpler path, as long as the choice is documented and applied to every similar case that follows.
A worked example makes the trade-off concrete. In a hypothetical quarter, a rep closes ten small deals and one large one. The accelerator that pushed the rep past quota can be traced to the large deal, but the amount tied to the ten small ones is small enough that the effort of testing each exceeds any reporting benefit. Allocating the bulk to the large contract and expensing the rest is a defensible call, and the memo records why.
The right answer is not fixed. A split that fits a small team selling one product can stop fitting once the company adds a second product line, a channel partner program, or a first enterprise contract with a long implementation. The treatment should follow the plan, and the plan rarely sits still for a year.
Stage matters more than size. Early on, sales are concentrated in a few deals and the commission file is short, so testing each contract is realistic. As volume grows, the portfolio approach becomes the only workable routine, and the decision shifts from how to treat one deal to Learn how it works to group thousands of similar ones.
Financing and transactions change the stakes. A lender looking at working capital will ask how long the commission asset takes to unwind. A buyer in diligence will ask whether the treatment is consistent and whether the benefit period is supported. Both questions are easier to answer when the reasoning has been written down from the start rather than assembled under time pressure.
In practice, three moments are worth a deliberate review:
Between those moments, leave the method alone. Rebuilding the split every quarter adds work and makes the reports harder to compare without changing the underlying economics of a single deal. The goal is a treatment that absorbs ordinary variation and reacts only when something real has moved.
Work through these items once with the plan document and a recent month of payouts in front of you. The goal is a defensible answer for each component, not a perfect model that anticipates every deal structure you might sign next year.
The decision criterion that survives board meetings and reviews is simple: capitalize only what you can explain in one sentence covering the trigger, the expected benefit, and the evidence behind the period. Everything else goes to expense, and that is a legitimate answer rather than a shortcut. What you cannot explain, you cannot defend, and an unexplained balance sheet item will be questioned every time.
Revisit the list when the commission plan changes or when churn moves enough to shift expected customer life. Between those moments, leave it alone and spend the time on the forecast instead.
No listing found.
Compare listings
Compare